fda compound tirzepatide Ban on Compounded GLP-1 Drugs: What to Know Speak up and share your

Interestingly, retatrutide achieves something similar by activating GLP-1, GIP, and glucagon receptors through a single molecule

But this drug hasnt been tested on people without or with slight overweight, so we dont conclusively know that its safe for those people

doi: 10.2147/ott.S235667 78 AmandaJSJosepFRobertJVOlgaBRenaeMR

Other possible side effects include diarrhea, constipation, headache, dizziness, fatigue, and low blood sugar levels, these effects are also usually mild and temporary

Report any persistent GI distress, unusual flushing, or signs of liver stress to your healthcare provider

Dr Samuel Cross of Imperial College London, one of the study's authors, noted that obesity and diabetes are chronic diseases that increase the risk of stroke, diabetes, heart disease, kidney failure, and cancer